| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.37 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.32 | 0.03 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |